The Longevity Registry

§ — Substance profile

C

BPC-157

Body Protection Compound 157 · Pentadecapeptide BPC 157 · Synthetic gastric-derived pentadecapeptide

01 — Regulatory status

Regulatory status · United States · as of October 2026

Not FDA-approved for any use. Removed from 503A Category 2 on April 15, 2026, after its nomination was withdrawn — which is not a listing in Category 1. On July 23, 2026, the Pharmacy Compounding Advisory Committee voted 8–6 (one abstention) to recommend it for the 503A Bulks List; FDA's own scientists had recommended against. FDA has not decided. It is not on the 503A Bulks List, so it cannot yet be compounded under section 503A.

Source: FDA 503A Bulks List · PCAC meeting records · verified October 2026

A
Approved drug with randomized controlled trials for the approved indication
B
Human clinical data exists, but no approval for the researched use
C
Animal or in-vitro data only, no controlled human trials
D
No published clinical data; use rests on anecdote

Reviewed October 2026 · Sources: FDA, EMA

02 — Researched for

What is being studied.

Tendon, ligament and muscle healing; gastrointestinal mucosal protection; ulcerative colitis (the indication FDA reviewed in 2026).

03 — What the evidence shows

The published record.

Extensive rodent data on tendon-to-bone healing and mucosal protection. Human data is limited to small, short trials FDA reviewers described as underpowered; no randomized controlled trial supports the injury-recovery use that dominates marketing.

04 — What is claimed but not shown

Claimed, not demonstrated.

Accelerated recovery from sports injuries in humans; systemic anti-inflammatory benefit; safety of long-term use.

05 — Known risks

Documented risks.

Immunogenicity and impurity concerns cited by FDA; unregulated sourcing means unknown purity and dose; no long-term human safety data.

06 — Researched for these goals

Where BPC-157 appears.

07 — Questions for your physician

Six questions worth printing.

  1. 01What is your primary board certification, and in what year did you obtain it?
  2. 02Is this peptide approved for what you are prescribing it for — and if not, what is the legal basis on which you are supplying it?
  3. 03Which human trials support this use, and what were their size and duration?
  4. 04Where does the product come from, and can you show me a certificate of analysis for this batch?
  5. 05What outcome will we measure, when, and what happens if it does not improve?
  6. 06What is the total cost for the first three months, in writing?

Practices near you that offer peptide therapy

Every practice in the registry that lists peptide therapy, sorted by distance and nothing else. You contact the practice directly.

Listed for transparency, not as an endorsement of any practice, substance or protocol. Most peptides are not FDA-approved for the uses they are offered for.

Reviewed October 2026 · Sources: FDA, EMA

This page reports on the state of research and regulation for orientation. It is not medical advice, not a recommendation for or against any substance, and not an offer. Regulatory status changes; the date shown is the date of our last verification. Discuss any treatment with a licensed physician.